Search Results - "CHATZIIOANNOU, S.N."

132 PREDISPOSAL MANAGEMENT OF MEDICAL SOLID RADIOACTIVE WASTE: THE UNIVERSITY GENERAL HOSPITAL OF ATHENS “ATTIKON” EXPERIENCE by Stefanoyiannis, A.P, Sagia, E, Geronikola-Trapali, X, Armeniakos, I, Prentakis, A, Chatziioannou, S.N

Get full text

The Education and training of clinical medical physicists in 25 European, 2 North American and 2 Australasian countries: Similarities and differences by Stefanoyiannis, A.P, Christofides, S, Psichis, K, Geoghegan, D.S, Gerogiannis, I, Round, W.H, Geronikola-Trapali, X, Armeniakos, I, Kaplanis, P.A, Prentakis, A, Chatziioannou, S.N

“…Abstract Purpose The clinical medical physicist is part of a team responsible for safe and competent provision of radiation-based diagnostic examinations and…”
Get full text

Radionuclide therapies (RNTs): Which is the radiation burden for the caregivers? by Stefanoyiannis, A.P, Gerogiannis, I, Ioannidou, S.P, Round, W.H, Carinou, E, Liotsou, T, Geronikola-Trapali, X, Armeniakos, I, Chatziioannou, S.N

Get full text

Peptide receptor radionuclide therapies (PRRTs): Which are the dosimetric data for the patients? by Stefanoyiannis, A.P, Chalkia, M.T, Gerogiannis, I, Round, W.H, Liotsou, T, Geronikola-Trapali, X, Armeniakos, I, Chatziioannou, S.N, Efstathopoulos, E.P, Nikiforidis, G.C

Get full text

The Role of PET scan in melanoma management by Chatziioannou, S.N.

Get full text

177Lu-Octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: dosimetry of personnel and caregivers by Stefanoyiannis, A.P., Liotsou, T., Ioannidou, S., Chatziioannou, S.N.

“…The clinical application of 177Lu-Octreotate Peptide Receptor Radionuclide Therapy (PRRTs) is well-established. The relatively long physical half life of…”
Get full text

177 Lu-Octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: dosimetry of personnel and caregivers by Stefanoyiannis, A.P, Liotsou, T, Ioannidou, S, Chatziioannou, S.N

“…Introduction The clinical application of177 Lu-Octreotate Peptide Receptor Radionuclide Therapy (PRRTs) is well-established. The relatively long physical half…”
Get full text

Radiation exposure of caregivers of patients undergoing PRRT with 177Lu-DOTATATE for the treatment of neuroendocrine tumors by Ioannidou, S.P., Stefanoyiannis, A.P., Carinou, E., Chatziioannou, S.N., Liotsou, T., Prentakis, A., Efstathopoulos, E.P.

Get full text

Radiation exposure of caregivers of patients undergoing PRRT with177 Lu-DOTATATE for the treatment of neuroendocrine tumors by Ioannidou, S.P, Stefanoyiannis, A.P, Carinou, E, Chatziioannou, S.N, Liotsou, T, Prentakis, A, Efstathopoulos, E.P

Get full text

Design and clinical implementation of a 99mTc-HYNICTOC-based dosimetric protocol in PRRT of NETs with 90Y-DOTATOC by Chalkia, M.T., Stefanoyiannis, A.P., Prentakis, A., Chatziioannou, S.N., Liotsou, T., Geronikola-Trapali, X., Armeniakos, I., Efstathopoulos, E.P., Nikiforidis, G.C.

Get full text

Design and clinical implementation of a99m Tc-HYNICTOC-based dosimetric protocol in PRRT of NETs with90 Y-DOTATOC by Chalkia, M.T, Stefanoyiannis, A.P, Prentakis, A, Chatziioannou, S.N, Liotsou, T, Geronikola-Trapali, X, Armeniakos, I, Efstathopoulos, E.P, Nikiforidis, G.C

Get full text

Pancreatic cancer's initial presentation: back pain due to osteoblastic bone metastasis by PNEUMATICOS, S.G., SAVIDOU, C., KORRES, D.S., CHATZIIOANNOU, S.N.

“…PNEUMATICOS S.G., SAVIDOU C., KORRES D.S. & CHATZIIOANNOU S.N. (2009) European Journal of Cancer Care19, 137–140
Pancreatic cancer's initial presentation: back…”
Get full text

Structured intercomparison of nuclear medicine physicians’ education and training programs in 12 EANM member-affiliated member countries by Stefanoyiannis, A.P., Prigent, A., Bakalis, S., Koutsikos, J., Arslan, N., Roach, P., Smidt, K.P., Soneji, N., Farmakis, G., Geronikola-Trapali, X., Armeniakos, I., Chatziioannou, S.N.

“…The nuclear medicine physician is a member of a team responsible for the safe and correct implementation of radioactivity-based procedures. To ensure the…”
Get full text

5.4 Prognostic value of myocardial perfusion imaging in women with non-significant coronary artery disease by Chatziioannou, S.N., Moore, W.H., Baswijit, K., Ford, P.V., Dhekne, R.D.

Get full text

Prognostic value of perfusion scintigraphy in high exercise tolerance by Chatziioannou, S.N, Moore, W.H, Dhekne, R.D, Ford, P.V

Get full text

Pancreatic cancer's initial presentation: back pain due to osteoblastic bone metastasis by PNEUMATICOS, S.G., SAVIDOU, C., KORRES, D.S., CHATZIIOANNOU, S.N.

Get full text